These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6547665)

  • 1. Experiences in the application of NONMEM to pharmacokinetic data analysis.
    Flühler H; Huber H; Widmer E; Brechbühler S
    Drug Metab Rev; 1984; 15(1-2):317-39. PubMed ID: 6547665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with NONMEM: analysis of routine phenytoin clinical pharmacokinetic data.
    Sheiner LB; Grasela TH
    Drug Metab Rev; 1984; 15(1-2):293-303. PubMed ID: 6547663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model.
    Steimer JL; Mallet A; Golmard JL; Boisvieux JF
    Drug Metab Rev; 1984; 15(1-2):265-92. PubMed ID: 6745083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis program MULTI(ELS) based on extended nonlinear least squares method for microcomputers.
    Yamaoka K; Tanaka H; Okumura K; Yasuhara M; Hori R
    J Pharmacobiodyn; 1986 Feb; 9(2):161-73. PubMed ID: 3754893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods.
    Sheiner LB
    Drug Metab Rev; 1984; 15(1-2):153-71. PubMed ID: 6745080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic data and parameter estimation based on their first two statistical moments.
    Beal SL
    Drug Metab Rev; 1984; 15(1-2):173-93. PubMed ID: 6745081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of population pharmacokinetic parameters using destructively obtained experimental data: a simulation study of the one-compartment open model.
    Lindstrom FT; Birkes DS
    Drug Metab Rev; 1984; 15(1-2):195-264. PubMed ID: 6745082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics.
    Mentré F; Gomeni R
    J Biopharm Stat; 1995 Jul; 5(2):141-58. PubMed ID: 7581424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Individualization of drug dosage by therapeutic monitoring in plasma and the application of pharmacokinetic principles].
    Klotz U
    J Clin Chem Clin Biochem; 1983 Nov; 21(11):649-58. PubMed ID: 6655441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KINPAK--a new program package for standardized evaluation of kinetic parameters.
    Betzien G; Kaufmann B; Schneider B; Ritschel WA
    Arzneimittelforschung; 1985; 35(1):14-20. PubMed ID: 3838671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NONLIN84/PCNONLIN: software for the statistical analysis of nonlinear models.
    Weiner DL
    Methods Find Exp Clin Pharmacol; 1986 Oct; 8(10):625-8. PubMed ID: 3784700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the number of exponential functions in pharmacokinetic models on the basis of concentration-time data by MUCOM1.
    Ulbrich M
    Methods Find Exp Clin Pharmacol; 1985 Dec; 7(12):653-9. PubMed ID: 3841683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics II: estimation methods.
    Ette EI; Williams PJ
    Ann Pharmacother; 2004 Nov; 38(11):1907-15. PubMed ID: 15367729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with NONMEM: analysis of serum concentration data in patients treated with mexiletine and lidocaine.
    Vozeh S; Wenk M; Follath F
    Drug Metab Rev; 1984; 15(1-2):305-15. PubMed ID: 6547664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE; Tett SE
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package.
    Gomeni R; Pineau G; Mentré F
    Anticancer Res; 1994; 14(6A):2321-6. PubMed ID: 7825966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KINPAK--a program for standardized pharmacokinetic analysis.
    Kaufmann B
    Methods Find Exp Clin Pharmacol; 1986 Oct; 8(10):615-24. PubMed ID: 3784699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.
    Comets E; Brendel K; Mentré F
    Comput Methods Programs Biomed; 2008 May; 90(2):154-66. PubMed ID: 18215437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.